Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Anovulatory cycle

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    6 result(s) found for: Anovulatory cycle. Displaying page 1 of 1.
    EudraCT Number: 2006-006514-15 Sponsor Protocol Number: RD-5103-015-06 Start Date*: 2007-11-26
    Sponsor Name:The University of Nottingham [...]
    1. The University of Nottingham
    2. Derby Hospitals NHS Foundation Trust
    Full Title: Double blind crossover randomised controlled trial comparing letrozole versus clomifene citrate for ovulation induction in women with polycystic ovarian syndrome
    Medical condition: Infertility due to polycycstic ovarian syndrome
    Disease: Version SOC Term Classification Code Term Level
    8.1 10021935 Infertility, female, associated with anovulation LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2020-004329-21 Sponsor Protocol Number: PE-PMA Start Date*: 2021-02-01
    Sponsor Name:OSPEDALE SAN RAFFAELE
    Full Title: Reduction of progesterone elevation at trigger in poor responder Bologna’ criteria patients after controlled ovarian stimulation with long acting standard stimulation protocol compared with convent...
    Medical condition: Patient with poor ovarian response
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004872 10021935 Infertility, female, associated with anovulation LLT
    Population Age: Adults Gender: Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-001379-20 Sponsor Protocol Number: 009 Start Date*: 2018-05-23
    Sponsor Name:Myovant Sciences GmbH
    Full Title: A Phase 2a Randomized, Double-Blind, Placebo and Active Comparator-Controlled, Parallel Group, Dose-Range Finding Study of MVT-602 in Healthy Premenopausal Women Undergoing Controlled Ovarian Stimu...
    Medical condition: Female infertility
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004872 10021935 Infertility, female, associated with anovulation LLT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2020-000866-41 Sponsor Protocol Number: 2019001_mife50 Start Date*: 2021-02-02
    Sponsor Name:Women on Web International Foundation
    Full Title: Combined Phase II/ III Multicentre Single-arm Trial of a Mifepristone 50 mg as a weekly Contraceptive
    Medical condition: Prevention of unwanted pregnancy
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: Outside EU/EEA
    Trial results: (No results available)
    EudraCT Number: 2020-002355-38 Sponsor Protocol Number: mife50 Start Date*: 2021-11-29
    Sponsor Name:women on web international foundation
    Full Title: Prospective multi-center single arm open label study of efficacy, safety and acceptability of long-term weekly oral Mifepristone 50 mg as contraceptive
    Medical condition: prevent pregnancy
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: Outside EU/EEA
    Trial results: (No results available)
    EudraCT Number: 2012-003227-38 Sponsor Protocol Number: EMR700623_535 Start Date*: 2013-03-07
    Sponsor Name:Merck Serono
    Full Title: A Multi-Centre, Two-Arm, Interventional, Phase IV Study to Evaluate Tailoring of Recombinant FSH Treatment in Subjects with Chronic Anovulation Using the Gonal-f® Prefilled Pen in Women Undergoing ...
    Medical condition: Anovulation in women with PCOS
    Disease: Version SOC Term Classification Code Term Level
    16.1 10042613 - Surgical and medical procedures 10033312 Ovulation induction PT
    16.1 100000004872 10065161 Polycystic ovarian syndrome LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed) IE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 08 07:40:28 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA